News Sanofi London S.E.

Equities

0A2V

US80105N1054

Market Closed - London S.E. Other stock markets 10:40:39 2023-10-27 am EDT			5-day change	1st Jan Change
41.75 ^USD	-21.08%		-14.36%	-15.81%

Jul. 03	Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division	MT
Jul. 03	Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division	Jul. 03	MT
Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division	Jul. 03	MT
Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division, Bloomberg Reports	Jul. 03	MT
SANOFI : Berenberg reiterates its Buy rating	Jul. 03	ZD
SANOFI : JP Morgan remains Neutral	Jul. 03	ZD
Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits	Jul. 03	MT
Sanofi Blockbuster Drug Dupixent Gets First-in-World Approval in Europe for COPD	Jul. 03	MT
Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval	Jul. 03	MT
Sanofi: approval of Dupixent for COPD in the EU	Jul. 03	CF
Sanofi obtains EU approval for Dupixent	Jul. 03	RE
Sanofi, Regeneron Get EU Approval for Dupixent to Treat Respiratory Disease	Jul. 03	DJ
Sanofi Wins EU Nod for Dupixent as Add-on Treatment for Chronic Obstructive Pulmonary Disease	Jul. 03	MT
EU approves Sanofi's Dupixent for 'smoker's lungs'	Jul. 03	RE
SANOFI SAYS DUPIXENT GRANTED EUROPEAN UNION APPROVAL TO TREAT…	Jul. 03	RE
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD	Jul. 03	GL
Regeneron Pharmaceuticals, Inc. and Sanofi Announces Approval in the European Union as the First-Ever Targeted Therapy for Patients with COPD	Jul. 03	CI
Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount	Jul. 02	MT
SANOFI : Jefferies reaffirms its Buy rating	Jul. 02	ZD
SANOFI : Receives a Buy rating from Berenberg	Jul. 02	ZD
Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits	Jul. 02	MT